OpenEvidence and iatroX overlap in helping clinicians investigate medical questions, but a useful comparison goes beyond their chat interfaces. Examine access, the sources supporting a particular answer, the jurisdiction of the question and what the clinician needs to do next. The products' broader workflows are not identical.
This comparison is published by iatroX and includes its own platform. Public product descriptions were checked on 20 September 2026. No authenticated head-to-head testing was performed, so the examples below do not attribute hypothetical answers or accuracy differences to either product.
At a glance: reference, access and learning
OpenEvidence's developer-published US app listing describes licensed medical content relationships, clinical answers, education and additional workflow functions. It is not accurately characterised as a search over PubMed abstracts alone. The same listing describes US professional verification, including an NPI requirement; that should not be generalised into an assured access route for every clinician or student worldwide. OpenEvidence's App Store listing
Ask-iatroX provides free clinical reference with linked sources, oriented towards UK guidance and medicines information. The wider platform also offers examination questions, Socratic Tutor, study planning, simulations and CPD tools. Access to the free reference service is distinct from its paid educational subscription. iatroX methodology
| Decision | What the reader should establish |
|---|---|
| Access | Whether the account is eligible for the intended product and feature |
| Sources | Which material supports the particular answer, not just the publisher logos |
| Jurisdiction | Whether the question and source match the intended clinical context |
| Follow-up | Whether uncertainty can be refined and checked |
| Learning | Whether the next task is research, question practice, rehearsal or documentation |
This map replaces a binary judgement based on company location. A UK-focused resource still needs checking; an international paper is not irrelevant merely because it was published elsewhere.
A hypertension question that needs a defined context
Consider the original comparison's broad example of a middle-aged adult and a hypertension question. The useful revision is to stop predicting what each application would answer. Without an actual run, it would be inappropriate to claim that one selects a particular medicine while the other follows a different guideline.
Instead, create a fictional prompt specifying the intended country, clinical setting and learning purpose. Ask which patient details and measurements would be necessary before reviewing a management recommendation. Then request the relevant underlying guidance, including its scope and publication or revision information.
Inspect whether the answer addresses the task supplied. Does it distinguish an initial assessment from follow-up of established treatment? Does it preserve the qualifiers in the source? Has a general evidence finding been mistaken for a local operational instruction?
No treatment recommendation is supplied here. The example teaches how to compare source use without manufacturing a clinical disagreement between products. A matched evaluation would record the exact prompts, outputs, product versions and review date before drawing conclusions.
Licensed content is a meaningful distinction, not an outcome measure
OpenEvidence's September 2026 listing identifies relationships with publishers and professional sources, including full-text content. Those relationships matter because they can affect what material a product can lawfully retrieve and present. They do not, by themselves, establish that every answer selects the right passage or interprets it correctly. OpenEvidence product description
The equivalent question for iatroX is also specific. Its published methodology describes retrieval, ranking, citation grounding, output checking and uncertainty handling. Those are design features to inspect, not a guarantee of universal correctness or an independently measured advantage over OpenEvidence. iatroX methodology
A clinician evaluating either answer should select a consequential statement and follow it to the source. A citation that supports a related background fact does not necessarily support the action proposed in the sentence. This is more informative than deciding which response contains more references.
Follow-up questions should narrow uncertainty
A productive follow-up changes the information problem. "Explain more" may produce additional prose without addressing the uncertainty. "Does that statement apply to this setting, and which part of the source establishes it?" creates something checkable.
For a fictional teaching case, record what the original answer assumed, what the follow-up clarified and what remains unresolved. Avoid adding unnecessary patient detail to a general-reference question. The privacy and permitted-use arrangements of the actual deployment must govern real clinical information.
The absence of a clear answer can also be useful. A source may not address the population, the product may not have the necessary material, or the question may depend on a local pathway. Acknowledging that limit is not the same as failing to produce enough text.
OpenEvidence is not only a reference search box
The current developer listing describes OpenEvidence Education with credit-related functions, alongside products such as Visits, Dialer and Voice Mode. Their existence does not establish availability in every account or country, but it does make older descriptions of OpenEvidence as lacking professional education or broader workflow features incomplete. OpenEvidence listing, checked 20 September 2026
This article does not compare those functions with unadvertised iatroX equivalents. iatroX is not being presented as an ambient scribe, a telephone system or an automated transfer of OpenEvidence activity into another platform.
Mobile access is likewise not a sufficient dividing line. Readers should test the specific task on their actual device rather than assume that an app's presence establishes feature parity with its web version.
From a clinical answer to examination practice
A UKMLA candidate has a different next step from a clinician preparing an evidence briefing. The candidate may need to answer an unseen question, explain a misconception and rehearse a consultation. A literature report alone does not complete those tasks.
iatroX's September 2026 learning description connects attempted questions with Socratic Tutor follow-up and provides relevant simulation tracks. Brainstorm can support educational case structuring, while the chosen examination pathway should determine the actual practice activity. This is a proposition to evaluate through use, not proof of improved pass rates. iatroX Tutor
Professional learning documentation also needs precise language. iatroX describes reviewed records and supported exports; those should not be treated as equivalent to every formal CE, CME or MOC arrangement advertised by another provider. iatroX CPD
Cost, governance and the reader's decision
As published on 20 September 2026, iatroX's UK all-access learning costs £99 upfront annually, equivalent to £8.25 a month billed annually, or £29 monthly. Paid banks, Tutor, planner, simulations and CPD are included together; free Ask-iatroX and free question access are separate from that purchase. OpenEvidence's published free US professional offer has eligibility requirements that should be checked directly.
The existing comparison's reference to iatroX's UKCA-marked, MHRA-registered Class I clinical-reference component concerns that component. It does not confer accreditation on examination preparation, prove comparative accuracy or justify describing a US supplier as having no governance.
For eligible readers investigating medical literature and OpenEvidence's documented clinical workflows, evaluate the actual OpenEvidence product. For UK-source clarification and a structured question-to-learning pathway, include iatroX. Where the tasks differ, complementary use may be more sensible than seeking a universal winner.
Frequently asked questions
Is OpenEvidence free for every clinician worldwide?
The reviewed US listing describes a verified-professional offer with US eligibility requirements. Do not assume those terms establish access for every profession, student or country.
Does OpenEvidence only search PubMed abstracts?
No: its current published description includes licensed full-text and professional content relationships. A fair comparison must inspect the sources behind an answer rather than rely on that outdated characterisation.
Does using iatroX require professional verification?
The free Ask-iatroX and free question-access routes do not require a professional-verification gate under the published September 2026 offer. Other activities, such as a saved learning session or paid subscription, have their own account requirements.